ArticleCancers2024

The Economic Impact of Treatment Sequencing in Chronic Lymphocytic Leukemia in Canada Using Venetoclax plus Obinutuzumab.

Kimberly Guinan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.